Clinical Trial Categories
Multiple Myeloma Trials
Trial ID BGB-11417-105
NCT04973605clinicaltrials.gov ID
Phase Ib/II
Trial ID 20285
NCT04782687clinicaltrials.gov ID
USOR ID: 20285
Phase II
A Phase II Trial of Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Combination with Selinexor for Patients with Newly Diagnosed Multiple Myeloma